Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.18T | 1.18T | 1.09T | 1.03T | 909.71B | 809.44B |
Gross Profit | 166.42B | 163.27B | 160.61B | 161.31B | 148.31B | 136.23B |
EBITDA | 93.56B | 73.67B | 93.40B | 97.13B | 91.06B | 79.55B |
Net Income | 34.45B | 34.45B | 56.04B | 59.33B | 54.49B | 48.26B |
Balance Sheet | ||||||
Total Assets | 1.37T | 1.37T | 1.35T | 1.20T | 1.08T | 953.66B |
Cash, Cash Equivalents and Short-Term Investments | 239.28B | 239.28B | 286.38B | 211.26B | 267.47B | 216.62B |
Total Debt | 420.00B | 420.00B | 415.00B | 391.50B | 311.84B | 267.95B |
Total Liabilities | 833.17B | 833.17B | 839.99B | 744.02B | 664.24B | 559.29B |
Stockholders Equity | 532.03B | 532.03B | 511.25B | 454.08B | 417.66B | 394.36B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -16.75B | 90.86B | -87.36B | 38.64B | 2.06B |
Operating Cash Flow | 0.00 | 3.92B | 115.02B | -51.91B | 65.45B | 31.88B |
Investing Cash Flow | 0.00 | -32.47B | -39.85B | -55.45B | -31.60B | -35.77B |
Financing Cash Flow | 0.00 | -20.55B | -753.00M | 50.78B | 15.73B | 66.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | €691.31B | 19.38 | 7.34% | 3.36% | 5.67% | -31.15% | |
61 Neutral | $18.09B | 12.97 | -1.60% | 2.98% | 1.42% | -15.92% | |
― | $4.48B | 12.31 | 5.08% | 3.89% | ― | ― | |
― | $15.21B | 11.79 | 10.34% | 4.08% | ― | ― | |
― | $7.33B | 10.23 | 12.58% | 2.09% | ― | ― | |
69 Neutral | ¥98.73B | 9.63 | 4.61% | 18.25% | 19.09% | ||
56 Neutral | ¥109.45B | 73.65 | 5.22% | -18.94% | -83.11% |
Haseko Corporation reported its consolidated financial results for the three months ended June 30, 2025, showing a slight increase in net sales by 0.4% compared to the previous year. The company experienced significant growth in operating profit and ordinary profit, with increases of 54.2% and 23.7% respectively, indicating improved operational efficiency and profitability. The financial forecast for the fiscal year ending March 31, 2026, anticipates continued growth in net sales and profits, reflecting a positive outlook for the company’s financial health and market position.